Wayne B. Weisman
Wayne has been a partner of SCP Partners since its inception and has been involved with private equity and venture capital investing since 1987. He joined Churchill Investment Partners, Inc. as a managing director in 1990 and became Vice President and a member of the board of directors of CIP Capital L.P., an SBIC, at the time of its founding in 1990. Wayne is co-founder and managing director of SCP Vitalife Partners, an Israel/U.S. venture fund focused on medical technology.
Wayne is a Director or Chairman of several companies, including Recro Pharma, ReWalk Robotics, LZ Therapeutics and Echo 360.
He also serves on the investment committee of Vitalife Life Sciences Fund.
From 1992 to 1994, Wayne served as Executive Vice President of Affinity Biotech, Inc., a drug delivery company, where he was responsible for strategic alliances, financial strategy, and mergers and acquisitions. He also oversaw its IPO and merger into the company that subsequently became IBAH, Inc., a leading contract research organization. From 1987 to 1990, Wayne operated a management and financial advisory firm.
Wayne began his career at the Philadelphia law firm of Saul, Ewing, Remick & Saul.
Wayne received his B.A. cum laude from the University of Pennsylvania and his J.D. from the University of Michigan Law School. He is the Chairman of the board of trustees of Young Scholars Charter School, an inner-city public school serving approximately 250 economically disadvantage children.
Home | Our Philosophy | Our Investment Strategy and Focus Areas | The SCP Team
Our Portfolio | SCP News | Contact Us |Submit a Business Plan
© 2007 SCP Partners. All Rights Reserved.
Wayne B. Weisman
Winston J. Churchill
Thomas G. Rebar
Robert G. Yablunsky
Richard L. Sherman
John M. Keane
Charles C. Freyer
Dennis P. Ferry
Danielle Del Grosso